(Q39014048)

8 September 2017

MicroRNA-494-3p targets CXCR4 to suppress the proliferation, invasion, and migration of prostate cancer (English)

1 reference

8 September 2017

1 reference

1 reference

Peng-fei Shen

1

1 reference

8 September 2017

Xue-qin Chen

2

1 reference

8 September 2017

Yong-chuan Liao

3

1 reference

8 September 2017

Ni Chen

4

1 reference

8 September 2017

Qiao Zhou

5

1 reference

8 September 2017

Qiang Wei

6

1 reference

8 September 2017

Xiang Li

7

1 reference

8 September 2017

Jia Wang

8

1 reference

8 September 2017

Hao Zeng

9

1 reference

8 September 2017

18 March 2014

1 reference

8 September 2017

1 reference

8 September 2017

74

1 reference

8 September 2017

7

1 reference

8 September 2017

756-767

1 reference

The role of CXC chemokines and their receptors in cancer.

8 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22795

The chemokine system in cancer biology and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22795

Emerging roles of chemokines in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22795

The CXCR4/SDF-1 chemokine axis: a potential therapeutic target for bone metastases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22795

Identification of anti-malarial compounds as novel antagonists to chemokine receptor CXCR4 in pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22795

Inhibition of chemokine (CXC motif) ligand 12/chemokine (CXC motif) receptor 4 axis (CXCL12/CXCR4)-mediated cell migration by targeting mammalian target of rapamycin (mTOR) pathway in human gastric carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22795

Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22795

Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22795

CXCL12 (SDF1alpha)-CXCR4/CXCR7 pathway inhibition: an emerging sensitizer for anticancer therapies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22795

CXCR4 expression in prostate cancer progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22795

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22795

MicroRNA signatures in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22795

Oncomirs - microRNAs with a role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22795

MicroRNA145 targets BNIP3 and suppresses prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22795

Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22795

microRNA expression in the biology, prognosis, and therapy of Waldenström macroglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22795

TEL-AML1 regulation of survivin and apoptosis via miRNA-494 and miRNA-320a

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22795

Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22795

MicroRNA alterations in head and neck squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22795

MicroRNA-494 suppresses cell proliferation and induces senescence in A549 lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22795

BCL-xL is a target gene regulated by hypoxia-inducible factor-1{alpha}.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22795

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22795

MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1alpha/HIF-1beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22795

Analysis of the inflammatory network in benign prostate hyperplasia and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22795

Understanding the immunoangiostatic CXC chemokine network

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22795

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22795

Loss of PTEN permits CXCR4-mediated tumorigenesis through ERK1/2 in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22795

New insights into the role of CXCR4 in prostate cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22795

Diverse signaling pathways through the SDF-1/CXCR4 chemokine axis in prostate cancer cell lines leads to altered patterns of cytokine secretion and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22795

Comparison of the potential multiple binding modes of bicyclam, monocylam, and noncyclam small-molecule CXC chemokine receptor 4 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22795

The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22795

Change in expression of miR-let7c, miR-100, and miR-218 from high grade localized prostate cancer to metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22795

miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22795

MicroRNA-494 targeting both proapoptotic and antiapoptotic proteins protects against ischemia/reperfusion-induced cardiac injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22795

MicroRNAs and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22795

Kaposi's sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 suppresses CXCR4 expression by upregulating miR-146a

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22795

MiR-1 is a tumor suppressor in thyroid carcinogenesis targeting CCND2, CXCR4, and SDF-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22795

The miR 302-367 cluster drastically affects self-renewal and infiltration properties of glioma-initiating cells through CXCR4 repression and consequent disruption of the SHH-GLI-NANOG network

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22795

21 January 2018

Identifiers

DOI

10.1002/PROS.22795

1 reference

8 September 2017

1 reference